FDA greenlights Bigfoot Biomedical ' s insulin recommending diabetes management system
The system was cleared for use among individuals 12 years old and up with Type 1 or Type 2 diabetes on multiple-dose injection therapy.
Source: mobihealthnews - Category: Information Technology Source Type: news
More News: Diabetes | Diabetes Type 1 | Diabetes Type 2 | Endocrinology | Information Technology | Insulin